Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Corcept Therapeutics Incorporated CORT

Full chart Compare
Set alert

Price alert · CORT

All alert types
79.22 USD -2.71 (-3.31%)

At closeNov 4, 2026, 5:30 PM EST

79.22 0.00 0.00%

After hours · Nov 4, 5:30 PM ET

71.29 Day range 84.98
28.66 52-week range 126.38
YTD
+127.64%
1 year
+11.42%

Financial health

Altman Z-Score

27.97 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A-4 / 5 overall

  • DCF 4
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 4
  • P/E 1
  • P/B 1

Valuation

P/E 36.6×
FY 2016: 104×FY 2017: 15.8×FY 2018: 22.3×FY 2019: 14.8×FY 2020: 28.4×FY 2021: 20.4×FY 2022: 21.4×FY 2023: 31.8×FY 2024: 37.3×FY 2025: 36.6×
FY 2016 5y median 31.8× FY 2025
P/S 4.7×
FY 2016: 9.9×FY 2017: 12.9×FY 2018: 6.7×FY 2019: 4.5×FY 2020: 8.5×FY 2021: 6.3×FY 2022: 5.4×FY 2023: 7.0×FY 2024: 7.7×FY 2025: 4.7×
FY 2016 5y median 6.3× FY 2025
P/B 5.6×
FY 2016: 19.4×FY 2017: 10.7×FY 2018: 6.1×FY 2019: 3.7×FY 2020: 5.8×FY 2021: 6.1×FY 2022: 4.3×FY 2023: 6.6×FY 2024: 7.7×FY 2025: 5.6×
FY 2016 5y median 6.1× FY 2025
P/FCF 25.5×
FY 2016: 44.1×FY 2017: 33.9×FY 2018: 14.6×FY 2019: 10.2×FY 2020: 20.0×FY 2021: 13.7×FY 2022: 18.1×FY 2023: 26.5×FY 2024: 26.6×FY 2025: 25.5×
FY 2016 5y median 25.5× FY 2025
EV/EBITDA 51.2×
FY 2016: 74.6×FY 2017: 36.7×FY 2018: 16.4×FY 2019: 11.9×FY 2020: 22.6×FY 2021: 17.3×FY 2022: 17.6×FY 2023: 25.4×FY 2024: 31.2×FY 2025: 51.2×
FY 2016 5y median 25.4× FY 2025
EV/Sales 4.6×
FY 2016: 9.4×FY 2017: 12.2×FY 2018: 5.9×FY 2019: 4.4×FY 2020: 8.3×FY 2021: 6.0×FY 2022: 5.2×FY 2023: 6.7×FY 2024: 7.5×FY 2025: 4.6×
FY 2016 5y median 6.0× FY 2025
FCF Yield 3.9%
FY 2016: 2.3%FY 2017: 3.0%FY 2018: 6.9%FY 2019: 9.8%FY 2020: 5.0%FY 2021: 7.3%FY 2022: 5.5%FY 2023: 3.8%FY 2024: 3.8%FY 2025: 3.9%
FY 2016 5y median 3.9% FY 2025

Profitability

Gross Margin 98.3%
FY 2016: 97.5%FY 2017: 97.8%FY 2018: 97.9%FY 2019: 98.2%FY 2020: 98.4%FY 2021: 98.6%FY 2022: 98.7%FY 2023: 98.7%FY 2024: 98.4%FY 2025: 98.3%
FY 2016 5y median 98.6% FY 2025
Operating Margin 5.9%
FY 2016: 12.5%FY 2017: 33.2%FY 2018: 35.6%FY 2019: 36.4%FY 2020: 36.2%FY 2021: 34.0%FY 2022: 28.0%FY 2023: 22.2%FY 2024: 20.3%FY 2025: 5.9%
FY 2016 5y median 22.2% FY 2025
Net Margin 13.1%
FY 2016: 10.0%FY 2017: 81.1%FY 2018: 30.0%FY 2019: 30.7%FY 2020: 30.0%FY 2021: 30.7%FY 2022: 25.2%FY 2023: 22.0%FY 2024: 20.7%FY 2025: 13.1%
FY 2016 5y median 22.0% FY 2025
ROE 15.4%
FY 2016: 19.7%FY 2017: 67.6%FY 2018: 27.3%FY 2019: 25.4%FY 2020: 20.3%FY 2021: 29.9%FY 2022: 20.2%FY 2023: 20.9%FY 2024: 20.6%FY 2025: 15.4%
FY 2016 5y median 20.6% FY 2025
ROIC 6.7%
FY 2016: 18.2%FY 2017: 27.7%FY 2018: 26.5%FY 2019: 24.0%FY 2020: 19.6%FY 2021: 29.7%FY 2022: 19.2%FY 2023: 17.7%FY 2024: 17.1%FY 2025: 6.7%
FY 2016 5y median 17.7% FY 2025
ROA 11.9%
FY 2016: 11.8%FY 2017: 58.5%FY 2018: 24.2%FY 2019: 22.8%FY 2020: 18.5%FY 2021: 26.6%FY 2022: 17.4%FY 2023: 17.1%FY 2024: 16.6%FY 2025: 11.9%
FY 2016 5y median 17.1% FY 2025

Growth (YoY)

Revenue 12.8%
FY 2016: 61.7%FY 2017: 95.8%FY 2018: 57.8%FY 2019: 22.0%FY 2020: 15.5%FY 2021: 3.4%FY 2022: 9.8%FY 2023: 20.0%FY 2024: 39.9%FY 2025: 12.8%
FY 2016 FY 2025
Operating Income -67.3%
FY 2016: 395.6%FY 2017: 419.3%FY 2018: 69.3%FY 2019: 24.7%FY 2020: 14.9%FY 2021: -2.9%FY 2022: -9.5%FY 2023: -4.8%FY 2024: 27.7%FY 2025: -67.3%
FY 2016 FY 2025
EPS (diluted) -33.3%
FY 2016: 216.7%FY 2017: 1385.7%FY 2018: -42.3%FY 2019: 28.3%FY 2020: 10.4%FY 2021: 4.7%FY 2022: -2.2%FY 2023: 8.0%FY 2024: 30.9%FY 2025: -33.3%
FY 2016 FY 2025
Free Cash Flow -27.6%
FY 2016: 484.5%FY 2017: 232.6%FY 2018: 90.6%FY 2019: 17.0%FY 2020: 11.6%FY 2021: 11.1%FY 2022: -28.4%FY 2023: 5.8%FY 2024: 54.4%FY 2025: -27.6%
FY 2016 FY 2025

Financial Health

Current Ratio 2.9×
FY 2016: 2.4×FY 2017: 4.8×FY 2018: 6.7×FY 2019: 7.9×FY 2020: 10.1×FY 2021: 5.6×FY 2022: 6.9×FY 2023: 4.4×FY 2024: 3.4×FY 2025: 2.9×
FY 2016 5y median 4.4× FY 2025
Quick Ratio 2.8×
FY 2016: 2.3×FY 2017: 4.5×FY 2018: 6.3×FY 2019: 7.8×FY 2020: 10.0×FY 2021: 5.5×FY 2022: 6.8×FY 2023: 4.3×FY 2024: 3.3×FY 2025: 2.8×
FY 2016 5y median 4.3× FY 2025
Debt / Equity 0.0×
FY 2016: 0.4×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -1.7×
FY 2016: -3.6×FY 2017: -2.0×FY 2018: -2.3×FY 2019: -0.2×FY 2020: -0.6×FY 2021: -0.6×FY 2022: -0.5×FY 2023: -1.1×FY 2024: -0.7×FY 2025: -1.7×
FY 2016 5y median -0.7× FY 2025
Interest Coverage 0.0×
FY 2016: 5.0×FY 2017: 1079×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31